Autori: Mistry Pramod K
| Naslov | Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2021), vol. 96 br. 9, str. 1156-1165 |
| Projekat | Sanofi GenzymeSanofi-AventisGenzyme Corporation |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2017), vol. 92 br. 11, str. 1170-1176 |
| Projekat | Sanofi Genzyme |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 21) |
| Info | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (2015), vol. 313 br. 7, str. 695-706 |
| Projekat | Genzyme |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
